Oscar Health, Inc. announced preliminary financial results for the second quarter of 2025, reporting a loss from operations of approximately $230 million and a net loss of about $228 million. These figures are based on an analysis of 2025 Marketplace data from Wakely, an independent actuarial firm. The company has revised its full-year 2025 guidance, now anticipating total revenue between $12.0 billion and $12.2 billion. Oscar Health expects a Medical Loss Ratio ranging from 86.0% to 87.0% and a Selling, General and Administrative (SG&A) Expense Ratio between 17.1% and 17.6%. The anticipated loss from operations for the full year is estimated to be between $300 million and $200 million. Additionally, the company projects an Adjusted EBITDA loss approximately $120 million less than the loss from operations. Oscar Health is set to release its detailed second-quarter 2025 financial results on August 6, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.